Investors Inject $257M Into Early Cancer Detection Co.
Thrive Earlier Detection said Wednesday that it has received $257 million from a group of investors led by Casdin Capital and Section 32, with plans to use the money to advance...To view the full article, register now.
Already a subscriber? Click here to view full article